Next |
home / stock / icpt / icpt message board
Subject | By | Source | When |
---|---|---|---|
Good read | Phoenix300 | investorshub | 05/20/2023 1:24:29 AM |
Did you type what you meant? Ocaliva has | DewDiligence | investorshub | 05/19/2023 10:21:16 PM |
Ocaliva is the classic example of a drug | sunspotter | investorshub | 05/19/2023 10:10:05 PM |
FDA advisory panel votes 15-1 against accelerated approval for Ocaliva in | DewDiligence | investorshub | 05/19/2023 9:38:20 PM |
is it bear time? Or do we go bull? | DewDiligence | investorshub | 05/19/2023 5:45:10 AM |
Price gaining | makinezmoney | investorshub | 05/17/2023 9:34:28 AM |
The gaining last up | DewDiligence | investorshub | 05/16/2023 2:17:50 AM |
$ICPT Long and strong lets hope im right | OverDraught | investorshub | 05/14/2023 3:37:23 AM |
Have a look at this | DewDiligence | investorshub | 05/13/2023 8:22:06 PM |
MomentumIts trading up | harry crumb | investorshub | 05/13/2023 9:18:16 AM |
$ICPT bulls and bears | Zilla | investorshub | 05/12/2023 12:09:22 AM |
$ICPT got some short data | DewDiligence | investorshub | 05/11/2023 9:55:59 AM |
$ICPT Price gaining up | harry crumb | investorshub | 05/11/2023 9:24:12 AM |
short data if anyone is interested | DewDiligence | investorshub | 05/09/2023 2:30:12 PM |
MomentumIts trading last up | whytestocks | investorshub | 05/07/2023 5:22:18 PM |
$ICPT Price trading | kingsransome | investorshub | 05/03/2023 4:54:31 PM |
$ICPT short squeeze all day | crudeoil24 | investorshub | 05/02/2023 8:16:23 PM |
$ICPT Anyone hear anything lately? Want to see this one go | sunspotter | investorshub | 05/01/2023 6:26:50 AM |
$ICPT short squeeze all day | Patrickwan1 | investorshub | 04/30/2023 8:50:39 AM |
$ICPT MomentumIts now last trade up | whytestocks | investorshub | 04/28/2023 6:52:01 AM |
News, Short Squeeze, Breakout and More Instantly...
Intercept Pharmaceuticals Inc. Company Name:
ICPT Stock Symbol:
NASDAQ Market:
Intercept Pharmaceuticals Inc. Website:
sNDA intended to satisfy post-marketing requirements to confirm a clinical benefit in patients with PBC Precedent-setting submission includes data from post-marketing studies COBALT and Study 401 as well as real-world evidence from a claims database and patient registries FDA has assign...
Monday, Gilead Sciences Inc (NASDAQ:GILD) agreed to acquire CymaBay Therapeutics Inc (NASDAQ:CBAY) for $32.50 per share i...
Data from two Phase 2 studies in PBC show combination of OCA + bezafibrate achieved biochemical remission (normalization of ALP, total bilirubin, GGT, ALT and AST) in 40-44% of patients in the first 12 weeks OCA 5 or 5-10 mg + bezafibrate 400 mg cohorts in both studies showed a >60% ...